ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2025 Earnings Call Transcript May 7, 2025
ACADIA Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $0.11, expectations were $0.1.
Al Kildani – SVP of IR & Corporate Communications:
Catherine Owen Adams – CEO:
Tom Garner – COO:
Elizabeth Thompson – EVP and Head of R&D:
Mark Schneyer – EVP and CFO:
Ritu Baral – TD Cowen :
Tessa Romero – JPMorgan:
Ash Verma – UBS:
Elaine Kim – Canter:
Basma Radwan – Leerink Partners:
David Huang –...
